Advertisement

CRY

GraniteShares YieldBOOST CRCL ETF

Healthcare · USD

Set alert

Price alert · CRY

All alert types
14.52 USD -0.37 -2.49%
As of Oct 30, 2026 Extended hours 14.52 0.00%
Bid
14.50 × 2
Ask
14.55 × 2
14.47 Day range 14.60
14.52 52-week range 25.93
YTD
-41.82%
1 year
-41.82%
Open
14.52
Prev close
14.89
Mkt cap
703.21M
Vol
21.75K
Avg vol
9.98K
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
14.47
High
14.60
Forward P/E
255.43
Beta
1.53
Short ratio
15.98
Inst. own
83.78%
Dividend
0.00
Ex-div date
Dec 8, 2015
Earnings
Feb 10, 2022
50-d avg
18.94
200-d avg
23.88
1y target
32.44

3M chart

Chart tools
Interval
CRY three-month price chart14.515.616.817.919.1Jul 31Aug 19Sep 8Sep 24Oct 13Oct 30

Key statistics

Market cap
703.21M
Enterprise value
1.04B
Trailing P/E
425.71
Forward P/E
255.43
PEG ratio
449.50
Price / sales
2.45
Price / book
2.26
EPS (TTM)
0.042
Beta
1.53
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.63%
Revenue (TTM)
287.34M
Revenue growth
10.90%
Free cash flow
3.38M
Total cash
64.59M
Total debt
363.37M
Return on equity
0.57%
Shares outstanding
39.33M
Short % of float
11.11%
50-day average
18.94
200-day average
23.88

Analyst view

Consensus: buy

Buy
Price target (mean) 32.44 +123.4% upside
Target (low)
25.00
Target (mean)
32.44
Target (high)
39.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy3
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Feb 10, 2022

Expected Feb 10, 2022. Consensus EPS estimate -0.10.

Earnings history

Earnings

CRY recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 10, 2022Dec 1, 2021-0.11———
Nov 4, 2021Sep 1, 20210.05———
Jul 29, 2021Jun 1, 2021-0.05———
Apr 29, 2021Mar 1, 2021-0.11———
Feb 11, 2021Dec 1, 2020-0.02———
Nov 4, 2020Sep 1, 2020-0.01———

Upgrades / downgrades

CRY analyst upgrades and downgrades
DateFirmActionFromTo
Jan 7, 2022Morgan Stanleymain—Equal-Weight
Jul 30, 2021Morgan Stanleymain—Equal-Weight
Jul 30, 2021Needhammain—Buy
Jul 15, 2021Morgan Stanleyinit—Equal-Weight
Apr 30, 2021Needhammain—Buy
Feb 12, 2021Needhammain—Buy

About GraniteShares YieldBOOST CRCL ETF

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; and cardiac laser therapy products, such as SolarGen 2100s Console and SoloGrip III disposable handpieces. Further, the company sells CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as offers pyrolytic carbon coating services to other medical device manufacturers. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. Artivion Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
artivion.com

News

Your note

Sign in to keep a note on CRY — it syncs with the Stock Master app.

Insider holders

CRY insider holders
InsiderRelationLatest transactionDateShares held
ACKERMAN THOMAS FDirectorStock Award(Grant)May 31, 2021119,695
BEVEVINO DANIEL JDirectorStock Award(Grant)May 31, 2021119,860
BORGSTROM MARNA P.DirectorStock Award(Grant)May 31, 202118,887
BULLOCK JAMES WDirectorStock Award(Grant)May 31, 202138,446
BURBANK JEFFREY HDirectorStock Award(Grant)May 31, 202123,595
HOLLOWAY JEAN FGeneral CounselSaleAug 30, 202186,567

Institution ownership

CRY institution ownership
Holder% heldSharesValueReported
Blackrock Inc.17.55%6,903,728153.88MSep 29, 2021
Wasatch Advisors Inc7.45%2,930,71565.33MSep 29, 2021
Vanguard Group, Inc. (The)6.46%2,539,38056.60MSep 29, 2021
Macquarie Group Limited5.55%2,182,88948.66MSep 29, 2021
Morgan Stanley4.39%1,727,15338.50MSep 29, 2021
Juniper Investment Company, LLC4.08%1,604,70735.77MSep 29, 2021

Fund ownership

CRY fund ownership
Holder% heldSharesValueReported
iShares Core S&P Smallcap ETF6.74%2,649,16254.68MOct 30, 2021
Wasatch Ultra Growth Fund5.86%2,304,90551.38MSep 29, 2021
Delaware Group Equity Fds V-Small Cap Core Fund4.60%1,811,03731.13MNov 29, 2021
Vanguard Total Stock Market Index Fund2.63%1,035,48823.08MSep 29, 2021
iShares Russell 2000 ETF2.26%887,47718.32MOct 30, 2021
Wasatch Microcap Fund1.42%560,00112.48MSep 29, 2021
Advertisement